April 3rd, 2025 |
John Nuss |
Chief Scientific Officer |
Sale
|
1.89K |
$2.02K |
467.23K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1887 |
$1.07 |
$2.02K |
|
April 1st, 2025 |
Raju Mohan |
Director, Officer: CEO And President |
Exercise
|
23.69K |
$- |
2.30M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
11844 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
11844 |
$0.00 |
$- |
|
April 1st, 2025 |
John Nuss |
Chief Scientific Officer |
Exercise
|
9.06K |
$- |
469.11K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
4531 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
4531 |
$0.00 |
$- |
|
April 1st, 2025 |
Somu Subramaniam |
Director |
Other
|
1.34M |
$- |
4.03M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Other
|
1335450 |
$0.00 |
$- |
|
March 12th, 2025 |
Somu Subramaniam |
Director |
Other
|
1.74M |
$- |
5.37M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Other
|
1735306 |
$0.00 |
$- |
|
January 3rd, 2025 |
John Nuss |
Chief Scientific Officer |
Stock Award
|
415.10K |
$888.32K |
245.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
245000 |
$2.14 |
$524.30K |
Stock Option (right to buy) |
Stock Award
|
170104 |
$2.14 |
$364.02K |
|
January 3rd, 2025 |
Raju Mohan |
Director, Officer: CEO And President |
Stock Award
|
700.00K |
$1.50M |
700.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
700000 |
$2.14 |
$1.50M |
|
January 3rd, 2025 |
Matthew Moore |
Chief Operating Officer |
Stock Award
|
145.00K |
$310.30K |
145.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
145000 |
$2.14 |
$310.30K |
|
January 3rd, 2025 |
Roy Gonzales |
Senior Vp, Finance |
Stock Award
|
126.70K |
$271.14K |
109.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
109200 |
$2.14 |
$233.69K |
Stock Option (Right to Buy) |
Stock Award
|
17500 |
$2.14 |
$37.45K |
|
January 3rd, 2025 |
Mark Forman |
Chief Medical Officer |
Stock Award
|
85.00K |
$181.90K |
85.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
85000 |
$2.14 |
$181.90K |
|
December 30th, 2024 |
John Nuss |
Chief Scientific Officer |
Sale
|
21.12K |
$49.84K |
464.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
21119 |
$2.36 |
$49.84K |
|
December 26th, 2024 |
Sheila Gujrathi |
Director |
Purchase
|
130.00K |
$300.57K |
130.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
130000 |
$2.31 |
$300.57K |
|
December 19th, 2024 |
John Nuss |
Chief Scientific Officer |
Exercise Sale
|
83.02K |
$29.68K |
498.86K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
34930 |
$0.00 |
$- |
Common Stock |
Sale
|
13161 |
$2.26 |
$29.68K |
Restricted Stock Units |
Exercise/Conversion
|
34930 |
$0.00 |
$- |
|
December 19th, 2024 |
Raju Mohan |
Director, Officer: CEO And President |
Exercise
|
233.34K |
$- |
2.29M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
116668 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
116668 |
$0.00 |
$- |
|
December 11th, 2024 |
John Nuss |
Chief Scientific Officer |
Exercise
|
397.87K |
$79.57K |
463.93K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
193557 |
$0.20 |
$38.71K |
Common Stock |
Exercise/Conversion
|
5377 |
$0.20 |
$1.08K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
193557 |
$0.20 |
$38.71K |
Stock Option (right to buy) |
Exercise/Conversion
|
5377 |
$0.20 |
$1.08K |
|
November 25th, 2024 |
Raju Mohan |
Director, Officer: CEO And President |
Purchase
|
500.00K |
$959.89K |
2.18M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
261752 |
$2.01 |
$524.94K |
Common Stock |
Purchase
|
238248 |
$1.83 |
$434.95K |
|
September 9th, 2024 |
Roy Gonzales |
Senior Vp, Finance |
|
155.00K |
$2.59M |
743 |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
|
0 |
$0.00 |
$- |
Stock Option (Right to Buy) |
|
12500 |
$4.67 |
$58.38K |
Stock Option (Right to Buy) |
|
37500 |
$2.14 |
$80.25K |
Stock Option (Right to Buy) |
|
35000 |
$2.49 |
$87.15K |
Stock Option (Right to Buy) |
|
70000 |
$33.84 |
$2.37M |
|
August 13th, 2024 |
Mark Forman |
Chief Medical Officer |
Stock Award
|
350.00K |
$682.50K |
350.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
350000 |
$1.95 |
$682.50K |
|
August 13th, 2024 |
Mark Forman |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
June 26th, 2024 |
Partners Nsv |
10 Percent Owner |
Other
|
641.33K |
$- |
7.10M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Other
|
641327 |
$0.00 |
$- |
|
June 26th, 2024 |
Somu Subramaniam |
Director, 10 Percent Owner: |
Other
|
641.33K |
$- |
7.10M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Other
|
641327 |
$0.00 |
$- |
|
June 11th, 2024 |
Raju Mohan |
Director, Officer: CEO And President |
Exercise
|
193.56K |
$38.71K |
1.68M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
96778 |
$0.20 |
$19.36K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
96778 |
$0.20 |
$19.36K |
|
June 7th, 2024 |
William White |
Director |
Stock Award
|
33.00K |
$108.41K |
33.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
33000 |
$3.29 |
$108.41K |
|
June 7th, 2024 |
Onaiza Cadoret-manier |
Director |
Stock Award
|
33.00K |
$108.41K |
33.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
33000 |
$3.29 |
$108.41K |
|
June 7th, 2024 |
Sheila Gujrathi |
Director |
Stock Award
|
33.00K |
$108.41K |
33.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
33000 |
$3.29 |
$108.41K |
|
June 7th, 2024 |
Allison Hulme |
Director |
Stock Award
|
33.00K |
$108.41K |
33.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
33000 |
$3.29 |
$108.41K |
|
June 7th, 2024 |
Somu Subramaniam |
Director, 10 Percent Owner: |
Stock Award
|
33.00K |
$108.41K |
33.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
33000 |
$3.29 |
$108.41K |
|
May 17th, 2024 |
Matthew Moore |
Chief Operating Officer |
Stock Award
|
320.00K |
$1.59M |
320.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
320000 |
$4.98 |
$1.59M |
|
May 17th, 2024 |
Matthew Moore |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
April 16th, 2024 |
Somu Subramaniam |
Director, 10 Percent Owner: |
Other
|
695.34K |
$- |
7.74M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Other
|
695339 |
$0.00 |
$- |
|
April 16th, 2024 |
Partners Nsv |
10 Percent Owner |
Other
|
695.34K |
$- |
7.74M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Other
|
695339 |
$0.00 |
$- |
|
April 3rd, 2024 |
Christopher Krueger |
Chief Business Officer |
Sale
|
1.65K |
$8.92K |
285.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1651 |
$5.40 |
$8.92K |
|
April 3rd, 2024 |
John Nuss |
Chief Scientific Officer |
Sale
|
1.65K |
$8.92K |
265.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1651 |
$5.40 |
$8.92K |
|
April 3rd, 2024 |
Raju Mohan |
Director, Officer: CEO And President |
Sale
|
4.31K |
$23.30K |
1.58M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4312 |
$5.40 |
$23.30K |
|
April 3rd, 2024 |
Martin Auster |
Chief Financial Officer |
Sale
|
1.41K |
$7.59K |
24.30K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1405 |
$5.40 |
$7.59K |
|
March 29th, 2024 |
Christopher Krueger |
Chief Business Officer |
Exercise
|
9.06K |
$- |
286.65K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
4531 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
4531 |
$0.00 |
$- |
|
March 29th, 2024 |
Martin Auster |
Chief Financial Officer |
Exercise
|
9.06K |
$- |
25.71K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
4531 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
4531 |
$0.00 |
$- |
|
March 29th, 2024 |
Raju Mohan |
Director, Officer: CEO And President |
Exercise
|
23.69K |
$- |
1.58M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
11843 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
11843 |
$0.00 |
$- |
|
March 29th, 2024 |
John Nuss |
Chief Scientific Officer |
Exercise
|
9.06K |
$- |
266.65K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
4531 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
4531 |
$0.00 |
$- |
|
January 23rd, 2024 |
William White |
Director |
Stock Award
|
20.00K |
$39.40K |
20.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
20000 |
$1.97 |
$39.40K |
|
January 23rd, 2024 |
Somu Subramaniam |
Director, 10 Percent Owner: |
Stock Award
|
20.00K |
$39.40K |
20.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
20000 |
$1.97 |
$39.40K |
|
January 23rd, 2024 |
Allison Hulme |
Director |
Stock Award
|
20.00K |
$39.40K |
20.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
20000 |
$1.97 |
$39.40K |
|
January 23rd, 2024 |
Onaiza Cadoret-manier |
Director |
Stock Award
|
20.00K |
$39.40K |
20.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
20000 |
$1.97 |
$39.40K |
|
January 23rd, 2024 |
Sheila Gujrathi |
Director |
Stock Award
|
80.00K |
$157.60K |
80.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
80000 |
$1.97 |
$157.60K |
|
January 3rd, 2024 |
Martin Auster |
Chief Financial Officer |
Stock Award
|
125.00K |
$311.25K |
125.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
125000 |
$2.49 |
$311.25K |
|
January 3rd, 2024 |
Raju Mohan |
Director, Officer: CEO And President |
Stock Award
|
155.00K |
$385.95K |
155.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
155000 |
$2.49 |
$385.95K |
|
January 3rd, 2024 |
John Nuss |
Chief Scientific Officer |
Stock Award
|
125.00K |
$311.25K |
125.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
125000 |
$2.49 |
$311.25K |
|
January 3rd, 2024 |
Christopher Krueger |
Chief Business Officer |
Stock Award
|
125.00K |
$311.25K |
125.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
125000 |
$2.49 |
$311.25K |
|
December 21st, 2023 |
John Nuss |
Chief Scientific Officer |
Sale
|
17.63K |
$37.33K |
262.12K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
17628 |
$2.12 |
$37.33K |
|
December 21st, 2023 |
Christopher Krueger |
Chief Business Officer |
Sale
|
5.29K |
$11.21K |
282.12K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
5293 |
$2.12 |
$11.21K |
|
December 21st, 2023 |
Raju Mohan |
Director, Officer: CEO And President |
Sale
|
58.86K |
$124.66K |
1.57M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
58860 |
$2.12 |
$124.66K |
|
December 19th, 2023 |
Raju Mohan |
Director, Officer: CEO And President |
Stock Award Exercise
|
707.09K |
$1.01M |
1.63M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
116668 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
473750 |
$2.14 |
$1.01M |
Restricted Stock Units |
Exercise/Conversion
|
116668 |
$0.00 |
$- |
|
December 19th, 2023 |
John Nuss |
Chief Scientific Officer |
Stock Award Exercise
|
251.11K |
$387.88K |
279.75K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
34931 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
181250 |
$2.14 |
$387.88K |
Restricted Stock Units |
Exercise/Conversion
|
34931 |
$0.00 |
$- |
|
December 19th, 2023 |
Christopher Krueger |
Chief Business Officer |
Stock Award Exercise
|
202.21K |
$387.88K |
287.41K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
10479 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
181250 |
$2.14 |
$387.88K |
Restricted Stock Units |
Exercise/Conversion
|
10479 |
$0.00 |
$- |
|
December 19th, 2023 |
Martin Auster |
Chief Financial Officer |
Stock Award
|
181.25K |
$387.88K |
181.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
181250 |
$2.14 |
$387.88K |
|
October 11th, 2023 |
Partners Nsv |
10 Percent Owner |
Sale
|
49.15K |
$1.48M |
8.44M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
49152 |
$30.03 |
$1.48M |
|
October 11th, 2023 |
Somu Subramaniam |
Director, 10 Percent Owner: |
Sale
|
49.15K |
$1.48M |
8.44M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
49152 |
$30.03 |
$1.48M |
|
October 6th, 2023 |
Raju Mohan |
Director, Officer: Chief Executive Officer |
Exercise Sale
|
90.00K |
$1.36M |
1.54M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
30000 |
$8.04 |
$241.20K |
Common Stock |
Sale
|
30000 |
$29.11 |
$873.23K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
30000 |
$8.04 |
$241.20K |
|
October 4th, 2023 |
Christopher Krueger |
Chief Business Officer |
Exercise Sale
|
45.00K |
$690.90K |
291.55K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
15000 |
$8.04 |
$120.60K |
Common Stock |
Sale
|
14006 |
$29.93 |
$419.19K |
Common Stock |
Sale
|
994 |
$30.70 |
$30.51K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
15000 |
$8.04 |
$120.60K |
|
October 4th, 2023 |
John Nuss |
Chief Scientific Officer |
Exercise Sale
|
30.00K |
$367.02K |
254.81K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
627 |
$8.04 |
$5.04K |
Common Stock |
Exercise/Conversion
|
7972 |
$3.54 |
$28.22K |
Common Stock |
Exercise/Conversion
|
1401 |
$0.20 |
$280 |
Common Stock |
Sale
|
9277 |
$29.94 |
$277.73K |
Common Stock |
Sale
|
723 |
$30.72 |
$22.21K |
Stock Option (right to buy) |
Exercise/Conversion
|
627 |
$8.04 |
$5.04K |
Stock Option (right to buy) |
Exercise/Conversion
|
1401 |
$0.20 |
$280 |
Stock Option (right to buy) |
Exercise/Conversion
|
7972 |
$3.54 |
$28.22K |
|
September 20th, 2023 |
Somu Subramaniam |
Director, 10 Percent Owner: |
Sale
|
56.66K |
$2.14M |
8.49M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
56665 |
$37.81 |
$2.14M |
|
September 20th, 2023 |
Partners Nsv |
10 Percent Owner |
Sale
|
56.66K |
$2.14M |
8.49M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
56665 |
$37.81 |
$2.14M |
|